SPONSORED CONTENT
TIP: When using outsourced telehealth services, be prepared to “Mind the Gap.”
Telehealth services are a great
SPONSORED CONTENT
TIP: When using outsourced telehealth services, be prepared to “Mind the Gap.”
Telehealth services are a great
SPONSORED CONTENT
Leaders of hospitals, health centers and other 340B provider institutions are busy and don’t have time in their demanding days to be involved in the detailed, day-to-day financial oversight of their 340B programs. Yet, they also can’t afford to leave valuable program dollars on the table, which fund vital and expanded patient services. Here’s a checklist of six key steps to help you optimize the financial health of your 340B program in 2023 and beyond. And if you have a 340B TPA (third-party administrator), this list can help you ask them the right questions.
SPONSORED CONTENT
With new contract pharmacy restrictions recently announced, and more expected to come in the near future, ensuring compliance is more important than ever in the world of 340B. Here are a few takeaways from last week’s 340B Coalition winter conference in San Diego to help you and your 340B program prepare for the changes ahead.
Drug manufacturers are getting increasingly restrictive regarding 340B pricing for contract pharmacy relationships. In just the past few days, Pfizer, GSK and Novartis have announced new restrictions, with GSK’s restrictions applying to all covered entities. Most of these companies are now only going to allow the use of 340B discounts in the contract pharmacy setting at the covered entity’s in-house retail pharmacy. The only exception is if the covered entity does not have an in-house outpatient pharmacy, they may designate one contract pharmacy location. In some of these instances, covered entities must also:
SPONSORED CONTENT
TIP: When approving your 340B wholesaler invoices for payment, make sure to compare the invoiced amount to your 340B catalog or the ceiling
SPONSORED CONTENT
TIP: For any covered entities with a contract pharmacy program, it is critical to review carve-out/ineligible claims data from your TPA system(s) to
SPONSORED CONTENT
Saving people’s lives.
Eliminating the stigma surrounding a host of physical and mental health conditions.
Advocating for the health equity of underserved populations.
Executing targeted marketing campaigns.
One of these initiatives indeed feels less service-oriented than the others. But once you kick all its associated buzzwords to the curb, marketing is crucial to a covered entity’s ability to fulfill its vision.
Whether it’s because they’re too busy fighting fires, feel like they don’t have the financial resources, or believe they lack the expertise to get the word out about their services successfully, covered entities often shy away from strategic marketing plans. Unfortunately, doing so can keep them from attracting and retaining patients and, as a result, threaten the sustainability of their missions.
Read on as Avita Care Solution’s Chief Marketing Officer Liz Eckert and Chief Advocacy Officer Glen Pietrandoni explain why covered entities must thoughtfully promote themselves to patients in an
…SPONSORED CONTENT
In 1999, the Centers for Disease Control and Prevention (CDC) launched the National Campaign to Eliminate Syphilis from the United States. The CDC updated its ambitious plan in 2006 and aimed to reduce rates of primary and secondary syphilis to less than 2.2 cases per 100,000 population, congenital syphilis to less than 3.9 cases per 100,000, and the racial disparity between rates of syphilis among Black and White individuals to less than 3:1. Despite having moderate success at the turn of the century, the US is experiencing a drastic resurgence of syphilis. In 2021, the CDC reported 171,074 total cases of syphilis nationally, a 68.4% increase from 2017. Worse, there has been a sharp increase in the number of babies born with syphilis; cases of congenital syphilis rose 184.5% to 2,677 cases between 2017 and 2021.
Like other sexually transmitted infections (STIs), syphilis disparities remain with regards to
…SPONSORED CONTENT
TIP: For sites submitting data to 340B ESP, the option exists within the 340B ESP portal to “Attest” for several manufacturers which will
SPONSORED CONTENT
With new leadership in Congress, the drumbeat for greater scrutiny of 340B will grow. To date, news outlets from The New York Times to The Wall Street Journal have quoted former government officials and pundits who’ve called for more oversight of the 340B program. It is not just former government officials that are raising concerns, leading lawmakers from both parties are calling on 340B providers to be more transparent and ensure that they are being good stewards of the program.
Regardless of the amount and kind of attention channeled toward the 340B program, it’s always right (and a best practice) for 340B executives and managers to be meticulous. Mock audits are one way for covered entities to closely watch over their 340B program activities. These rehearsals can help program managers, staff, and healthcare employees ensure compliance and pass an audit by the
…SPONSORED CONTENT
It’s that time again: The 340B Coalition Winter Conference, known as the can’t-miss gathering of covered entities, health care providers, pharmacy and pharmacy service providers, drug manufacturers, government agencies, and other organizations dedicated to driving health equity for underserved populations via the 340B drug discount program, is just around the corner.
Over the course of three days, the event draws thousands of industry insiders, features a full program of educational, networking, and demo sessions, and showcases approximately 70 exhibitors. But with so much on the agenda—during a critical year for insights and collaboration into the changing 340B world—how can attendees get the most bang for their collective bucks?
Find out below as Avita Care Solutions leaders (and veteran 340B Coalition Conference-goers) Michael Yount and Lee Horner weigh in with tips on using the event to find thought leaders and make lasting partnerships. And don’t
*Sign up for news summaries and alerts from 340B Report